prof. Veerle Surmont
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent - VEERLE.SURMONT@UGent.be
Show
Sort by
-
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)
-
Application of an Ultrasensitive NGS-Based Blood Test for the Diagnosis of Early-Stage Lung Cancer: Sensitivity, a Hurdle Still Difficult to Overcome
-
- Journal Article
- A2
- open access
Neurocognitive functioning following lung cancer treatment : the PRO-Long study
-
- Journal Article
- A1
- open access
Application of an ultrasensitive NGS-based blood test for the diagnosis of early-stage lung cancer : sensitivity, a hurdle still difficult to overcome
-
Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials
-
- Journal Article
- A1
- open access
Real life data on patient-reported outcomes and neuro-cognitive functioning of lung cancer patients : the PRO-long study
-
Coping strategy influences quality of life in patients with advanced lung cancer by mediating mood
-
- Miscellaneous
- open access
Lung Cancer in Belgium
-
Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial
-
- Journal Article
- A1
- open access
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial